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CASE REPORTS 
Atherectomy of the Left Main Coronary 
Artery with Percutaneous Cardiopulmonary 
Bypass Support 
David W.M. Muller, MBBS, Stephen G. Ellis, MD, and Eric J. Topol, MD 
L eft main (LM) coronary ar- tery stenoses have conventionally 
been precluded from percutaneous 
coronary angioplasty because of the 
prohibitive risk of irreversible hemo- 
dynamic collapse after acute closure 
of the artery, and a relatively high 
risk of late sudden death. l When pro- 
tected by left anterior descending 
and circumflex coronary artery by- 
pass grafts, angioplasty of the LM 
coronary artery can be safely per- 
formed but is limited by a rate of 
recurrent stenosis in excess of 50%.* 
Coronary atherectomy has recently 
been advocated as an alternative pro- 
cedure because of preliminary data 
suggesting a lower incidence of acute 
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closure and restenosis after peripher- 
al atherectomy. 3 A percutaneous 
cardiopulmonary support system has 
also been reported to reduce the haz- 
ards of high risk conventional angio- 
plasty including angioplasty of the 
LM coronary artery.4 We report the 
successful combined use of percuta- 
neous cardiopulmonary bypass and 
LM coronary atherectomy in a pa- 
tient incompletely protected by aor- 
tocoronary bypass grafts. 
Following an anterior wall myo- 
cardial infarction, a 58-year-old 
man underwent coronary artery by- 
pass graft surgery and left ventricu- 
lar aneurysmectomy in February 
1982. Saphenous vein grafts were 
anastamosed to the left anterior de- 
scending artery, the obtuse marginal 
branch of the circumflex coronary 
artery and the posterolateral and 
posterior descending branches of the 
right coronary artery. He thereafter 
remained asymptomatic until Feb- 
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ruary 1988 when he developed recur- 
rent Canadian Heart Association 
class IV angina. An exercise thalli- 
um study demonstrated inferior, ap- 
ical and posterior defects with redis- 
tribution consistent with ischemia. 
Coronary angiography showed a 
70% distal LM coronary stenosis, 
complete occlusion of the midleft 
anterior descending and the proxi- 
mal right coronary arteries and sub- 
total occlusion of the obtuse margin- 
al branch of the circumflex coronary 
artery. The vein graft to the postero- 
lateral branch of the right coronary 
artery was occluded but the remain- 
ing grafts were patent. Coronary an- 
gioplasties of the distal LM and 
obtuse marginal stenoses were suc- 
cessfully performed with good 
symptomatic response. Symptoms 
recurred, however, in September 
1988. Repeat coronary angiography 
showed recurrence of the LM and 
obtuse marginal branch stenoses, oc- 
clusion of the obtuse marginal and 
right coronary grafts and develop- 
ment of a long, irregular stenosis in 
the midleft anterior descending ar- 
tery distal to the insertion of the sa- 
phenous vein graft. Coronary angio- 
plasties of the left anterior descend- 
ing artery and obtuse marginal 
stenoses were then performed with a 
reduction in caliper-measured ste- 
nosis severity from 85 to 11% and 85 
to Id%, respectively. Despite the sat- 
isfactory angiographic results, no 
symptomatic improvement was ap- 
parent and he was readmitted in No- 
vember 1988. Repeat angiography 
showed minimal residual stenosis at 
the sites of recent coronary angio- 
plasty and no change in the severity 
of the 70% distal LM coronary ste- 
nosis (Figure 1). Although it would 
be incompletely protected by coro- 
nary bypass grafts, coronary ather- 
ectomy was the procedure preferred 
because of the early recurrent steno- 
sis after balloon angioplasty and the 
patient’s desire to avoid a second 
surgical procedure. 
To provide optimal hemoa’ynam- 
ic support during the procedure, car- 
diopulmonary bypass was initially 
instituted using the Bard cardiopul- 
monary support device. Right femo- 
ral arterial (20 Fr) and venous (22 
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Fr) cannulas were inserted percuta- time was monitored throughout the pass of the device. These electrocar- 
neously under local anesthetic. procedure. Atherectomy of the distal diographic changes were not associ- 
Commencement of bypass resulted LM stenosis was then performed ated with chest pain or hypotension 
in transient systemic hypotension, through an 11 Fr left coronary guid- and resolved rapidly after removal 
which was readily corrected by the ing catheter advanced from the left of the catheter. After minimal resid- 
administration of additional fluids femoral artery. A 7 Fr Simpson di- ual stenosis was demonstrated (Fig- 
through the support system. There- rectional atherectomy device (Figure ure 3), the atherectomy catheter was 
after, systemic systolic pressure re- 2) was used to remove 12 cores of removed, the tissue obtained sent for 
mained between 85 and 110 mm Hg tissue. Placement of the device re- histologic examination and the sup- 
with bypass flow rates of 3.5 to 4.5 sulted in 2 mm of ST-segment eleva- port system access site surgically 
literslmin. A total of 30,000 U of tion in monitored leads II and V’s closed. The postoperative course was 
heparin was administered intrave- commencing soon after left main oc- uneventful apart from the need for a 
nously and partial thromboplastin clusion and lasting throughout each 9-unit blood transfusion due to 
flGURE 2. Right anterior ablique proSaction shows the aWredomy device posit&d within the left main coromuy artery. 
FtGURE 3. Barn of the left main coronaryarteryafter suxedul atbemhmy shows miniial residual stenosis. The 
22 Fr m ecwbopulmonary bypass cannula tying within the right atrium is indicated by the arrow. 
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losses within the support system and 
perioperative access site hemor- 
rhage. A predischarge exercise thal- 
lium study showed a smallfixed ap- 
ical defect but no reversible isch- 
emia. The patient was discharged 7 
days postoperatively receiving cou- 
madin and diltiazem and has re- 
mained asymptomatic with no evi- 
dence of provocable ischemia during 
the 5-month follow-up period. 
Technological advances in dilata- 
tion catheter and guidewire design 
have greatly facilitated complex cor- 
onary angioplasty. Unprotected bal- 
loon angioplasty of the LM coronary 
artery, however, has remained rela- 
tively contraindicated because of the 
risk of acute closure and cardiogenic 
shock and the inability to perform 
prolonged balloon inflations. Several 
alternatives5 are being evaluated to 
reduce the severity of myocardial 
ischemia during LM coronary inter- 
ventions and may reduce the likeli- 
hood of restenosis. During conven- 
tional balloon angioplasty, myocardi- 
al ischemia may be minimized 
directly using an autoperfusion bal- 
loon catheter or by infusing fluori- 
nated hydrocarbons into the distal 
coronary circulation through the cen- 
tral lumen of the dilatation catheter. 
Alternatively, the use of coronary si- 
nus retroperfusion techniques, percu- 
taneous cardiopulmonary support or 
intraaortic balloon counterpulsation 
may indirectly reduce myocardial 
ischemia. Although these strategies 
may permit prolonged balloon infla- 
tions, this has not yet been shown to 
reduce the incidence of intimal dis- 
section or restenosis. 
Two promising alternatives are 
being investigated. Coronary ather- 
ectomy, fust reported by Simpson et 
a1,6 has been successfully used in the 
LM coronary artery and preliminary 
data from peripheral vascular proce- 
dures suggest that the recurrence 
rate may be significantly reduced af- 
ter this procedure. Adequate long- 
term follow-up studies, however, 
have not yet been completed. Second, 
a variety of endoluminal stents have 
been developed but, to date, these 
have not been deployed in the LM 
coronary artery. In this patient, the 
Coronary Artery Thermal Damage During 
Percutaneous **Hot Tip” Laser-Assisted 
Angioplasty 
Eric Rosenthal, MB, ChB, MRCP, Joseph K. Montarello, MB, BS, FRACP, 
Tim Palmer, MB, BS, MRCPathol, and Paul V.L. Curry, MD 
A major postulated advantage of laser angioplasty as an alterna- 
tive treatment for occlusive vascular 
disease is its ability to vaporize ob- 
structive atheroma.lJ The bare fiber 
systems used initially in the peripher- 
al vasculature were able to traverse 
occlusions but the channels produced 
were small, subsequent balloon dila- 
tation was always necessary and a 
high perforation rate was noted.3 The 
“hot tip” laser thermal probe pro- 
duced by encasing the bare fiber tip 
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in a metal cap4 overcame some of 
these limitations. The relatively 
large, smooth and oval metal cap en- 
hanced coaxial placement while lo- 
calization of all the laser energy (by 
heat conversion) at the tip made per- 
forations infrequent.sy6 In the periph- 
ery this device recanalized lesions 
previously impassable to a guidewire 
and balloon system.7 For intracoro- 
nary use the smaller peripheral ar- 
tery probes (1.5 to 1.7 mm tips) were 
modified to include an eccentric 
guidewire channel through the tip to 
facilitate coaxial advancement and 
subsequent balloon exchange. Percu- 
taneous use of this probe in coronary 
artery disease has produced mixed 
results.8-‘0 In this report we present 
experience using a more flexible laser 
thermal device. 
combined use of 2 of these emerging 
strategies allowed thorough removal 
of atheromatous plaque in the LM 
coronary artery. Although experi- 
ence with each device is limited and 
long-term follow up incomplete, this 
combination of new technologies ap 
pears to offer the potential for the 
expansion of the indications for per- 
cutaneous coronary intervention, ob- 
viating the need for coronary surgery 
in selected high risk situations. 
1. Hartzler GO, Rutherford BD, McConahay DR, 
Johnson WL, Giorgi LV, Cakins M, Lignon R. Left 
main coronary angioplasty--a caution (abstr). 
MCC 1988;11(suppl2):61A. 
2. Demopolous P, Selmon M, Simpson J, McAuley 
B. Percutaneous balloon angioplasty of left main car- 
onary stenoses-acute and long term results (abstr). 
JACC 1988;l I (suppl 2):61A. 
3. Selmon MR. Robertson GC. Simmon JB. Reste- 
n&s in peripheral translumina~athekctomy (abstr). 
Circulation 1988;(suppl 11)78:11-269. 
4. Vogel RA. The Maryland experience: angioplasty 
and valvuloplasty using percutaneous cardiopulme 
nary support. Am J Cardiol 1988,62:11 K-14K. 
5. Top01 El. Emerging strategies for failed percuta- 
neous transluminal coronary angioplasty. Am J Car- 
diol 1989,63:249-250. 
6. Simpson JB, Robertson GC, Selmon MR. Percu- 
taneous coronary atherectomy (abstr). Circulation 
1988,~suppl D-)78:11-82. 
We used a laser probe comprised 
of a 116 p core optical fiber con- 
tained in a soft polyurethane cathe- 
ter (Trimedyne Inc.). The distal 2 
cm of thefiber, between the catheter 
and the 1.7-mm diameter tip, was 
enclosed in ajloppy spiral metal coil 
that further enhanced the probe 
flexibility. A guidewire channel 
passed up the length of the catheter 
and through the center of the tip al- 
lowing it to be advanced over a 
0.01 I-inch guidewire. An Optilase 
argon laser (Trimedyne Inc.) set at 
10 watts (>80% coupling efficiency) 
was used to heat the tip. 
Patients in whom balloon angio- 
plasty had been or was likely to be 
unsatisfactory were considered for 
percutaneous laser thermal probe- 
assisted angioplasty. Our standard 
angioplasty regimen includes hepa- 
rin 10,000 U during the procedure; in 
addition aspirin 300 mg 3 times/day 
and dipyridamole 100 mg 3 times/ 
day were commenced 2 days before 
the procedure. A temporary pacing 
electrode was placed in the right ven- 
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